昆明流产得花多少钱-【昆明台俪妇产医院】,昆明台俪妇产医院,昆明那个医院做人流比较好,做流产去昆明哪家医院好,昆明那里妇科好,昆明流产需要多长时间,昆明打胎收费标准,昆明好的人流医院在哪
昆明流产得花多少钱昆明市打胎具体费用,昆明流产大概花费用,昆明怀孕多少天打胎孩子好,台俪妇科医院营业时间,昆明西山区妇科医院哪家好,昆明哪的人流医院比较好,昆明哪里有打胎的医院
WELLINGTON, May 24 (Xinhua) -- New Zealand researchers have found a way to stop the growth of certain cancer tumors by " silencing" a group of PAX genes, members of a small family of genes that play important roles in embryonic development, but also allow cancer cells to grow and divide in adult tissue.In an article published in UK medical journal Oncogene, Otago University Professor Michael Eccles and colleagues revealed how they used the PAX8 gene to kill cancer cells.After detecting high levels of PAX8 protein in the majority of kidney, ovarian and thyroid cancers they studied, the researchers used molecular techniques to silence the PAX8 gene in several cancer cell lines."We found that these PAX8-depleted cancer cells ceased growing and dividing. The cells were essentially stopped in their tracks through the failure of multiple mechanisms and pathways crucial to their cell division cycle. They then entered into a state called senescence in which they no longer divided, and after that they ultimately died," Eccles said in a statement from the university Tuesday.The findings suggested that PAX8 could be a good target for the development of new cancer therapies, he said."Any resulting drugs would be a long way down the road, but in the meantime this research helps confirm that a focus on PAX genes may prove to be a fruitful line of attack against a number of cancers," he said.The research was supported by grants from the Health Research Council of New Zealand. It formed the main piece of work carried out by Otago doctoral graduate Caiyun (Grace) Li, now a postdoctoral fellow at Stanford University. Study co-authors also included Professor Antony Braithwaite and master's student Jen Nyman.In 2003, research led by Eccles discovered that proteins from one or more of the nine PAX genes were present in many common cancers. They found that "silencing" the gene expression of PAX2 in ovarian and bladder cancer cells, and of PAX3 in melanoma, led to the rapid death of the cells.
WASHINGTON, April 6 (Xinhua) -- A study led by researchers at the University of Michigan (U-M) showed in animal studies that new cancer drug compounds they developed shrank tumors, with few side effects.The study, done in two mouse models of human cancer, looked at two compounds designed to activate a protein that kills cancer cells. The protein, p53, is inactivated in a significant number of human cancers. In some cases, it is because another protein, MDM2, binds to p53 and blocks its tumor suppresser function. This allows the tumor to grow unchecked. The new compounds block MDM2 from binding to p53, consequently activating p53."For the first time, we showed that activation of p53 by our highly potent and optimized MDM2 inhibitors can achieve complete tumor regression in a mouse model of human cancer," says lead study author Shaomeng Wang, director of the Cancer Drug Discovery Program at the U-M Comprehensive Cancer Center.Wang presented the study Wednesday at the American Association for Cancer Research 102nd annual meeting.Many traditional cancer drugs also activate p53 but they do so by causing DNA damage in both tumor cells and normal cells, causing side effects. These new MDM2 inhibitors activate p53 while avoiding the DNA damage common with other drugs. In this study, which was done in collaboration with Ascenta Therapeutics and Sanonfi-Aventis, researchers showed that these new drugs shrank tumors without significant side effects.Because p53 is involved in all types of human cancer, the new drug has potential to be used in multiple types of cancer. Further, the researchers also identified certain markers in tumors that predict which ones will be particularly sensitive to the MDM2 inhibitor, which would allow physicians to target the drug only to patients most likely to benefit.
WASHINGTON, April 13 (Xinhua) -- The U.S. Food and Drug Administration (FDA) announced on Wednesday that it has approved the cPAX Aneurysm Treatment System for surgery on brain aneurysms that are difficult to manage because of their size and shape.An aneurysm is a bulge in the wall of a blood vessel, which can rupture as it increases in size, causing hemorrhage or death. Brain aneurysms often produce no symptoms until they grow and press on nerves in the brain, or until they begin to leak blood or rupture.Aneurysms can be repaired in two ways: surgeons can close the base of the aneurysm with a surgical clip, or use a technique commonly known as coiling, in which surgeons use a catheter to thread metallic coils through a blood vessel in the groin and into the blood vessel in the brain that contains the aneurysm. Surgeons then fill the aneurysm with the detachable coils, which block it from circulation and cause blood to clot, effectively destroying the aneurysm.Aneurysms larger than 10 millimeters are difficult to treat with clipping or coiling. The cPAX device system is indicated for use in those brain aneurysms."Like coiling, the cPAX Aneurysm Treatment System is a form of endovascular repair," said Christy Foreman, director of the Office of Device Evaluation in the FDA's Center for Devices and Radiological Health. "But instead of tiny metallic coils, it uses a special polymer material to fill the space within the aneurysm."According to the FDA, the cPAX device system is indicated for use in adults aged 22 and older and should not be used in patients with an active infection or in those in whom anticoagulation and antiplatelet therapy is contraindicated.
BEIJING, Feb. 12 (Xinhua) -- The Chinese government has reiterated a strict ban on hepatitis B tests during pre-employment physical examinations as many companies reportedly violated rules to require hepatitis B tests for job applicants.In a statement released Saturday, the Ministry of Health said that no health institutions are allowed to provide hepatitis B checks as part of pre-employment physical tests regardless of whether the examinees provide consent or not.On Feb. 10, 2010, the Ministry of Health, the Ministry of Education and the Ministry of Human Resources and Social Security jointly issued a circular demanding the cancellation of the hepatitis B tests during the health checks for school enrollment and employment nationwide.However, according to a survey released this week, which was conducted by the non-profit Beijing Yirenping Center, some 61.1 percent of the 180 state-run companies surveyed included hepatitis B checks in their pre-employment physical examinations.More surprisingly, 63 companies said that they would never consider hepatitis B carriers for a job or were reluctant to hire such people.Yu Fangqiang, the principal of the Yirenping Center, said that such violations mainly resulted from light punishment for violations and some health institutions' desire for profits.According to the survey, employers would only be fined between thousands to tens of thousands of yuan if they lose their lawsuits for bias against hepatitis B carriers.Meanwhile, a worker will spend a lot of time, energy and money to file a lawsuit and collect evidence in order to win.Liu Xiaonan, an associate professor with the China University of Political Science and Law, called on the government to hammer out a particular law and set up a special committee to investigate discrimination cases in order to ensure the rights of workers.In the statement released Saturday, the health ministry also ordered a careful investigation of all cases of hepatitis B discrimination, and promised that violators would be exposed and punished in accordance with laws and regulations.Medical tests show that hepatitis B virus can only be transmitted from mother to child during childbirth or by contact with the blood or other body fluids of an infected person.
SAN FRANCISCO, April 27 (Xinhua) -- Apple Inc. on Wednesday denied the alleged location-tracking practice of its mobile operating system, saying it will release software updates to make iPhone store less location information to quell public concerns over privacy.CLARIFICATION"Apple is not tracking the location of your iPhone. Apple has never done so and has no plans to ever do so," the company said in a statement."Users are confused, partly because the creators of this new technology (including Apple) have not provided enough education about these issues to date."According to the statement, the location data researchers saw on iPhone is a database of Wi-Fi hotspots and cell towers around users' current location that Apple is maintaining to help iPhone rapidly and accurately calculate its location when requested. It noted Apple cannot locate iPhone users based on Wi-Fi hotspot and cell tower data as the information is in an anonymous and encrypted form.Apple admitted that part of the location data (Wi-Fi hotspots and cell towers) is backed up on iTunes, which means it could be possible that people with access to iPhone users'computer may get their location information. It said a software update has been planned to cease the backing-up.It is also planning to provide an update to limit the data storage on iPhone, in response to questions that the device has been storing location data since the release of iOS 4 operating system last June.Apple said it is a bug that iPhone keeps storing location data even if its location services are disabled, noting it will fix this through a software update in the coming weeks.The company also reiterated its focus on personal information security and privacy."Pretty much what I expected at this stage. The response is measured and the update should fix the problem," Alasdair Allan, one of the two British researchers who first announced the discovery of stored location data on iPhone, said on his Twitter account.ALLEGATIONThe statement on Wednesday is Apple's first official response to the location-tracking allegations.Worries on the iPhone tracking issue first surfaced last Wednesday when two British researchers announced at a technology conference in California that iPhone has been collecting users' location information and storing the data since June 21, 2010.Last Friday, The Wall Street Journal reported its security analysts had found that Apple's iPhone and smartphones running Google's Android operating system regularly transmit users' locations back to the two companies respectively, which is part of their race to build databases capable of pinpointing people's locations via smartphones.The newspaper then reported on Sunday that its analysts had also found iPhone is collecting and storing user's location data even when location services are turned off.PRESSUREThe Cupertino, California-based company has been facing mounting pressure from lawmakers, customers as well as media reports following the revelations.The U.S. House Energy and Commerce Committee on Monday sent letters to six developers of mobile device operating systems, including Apple and Google, demanding Apple's explanation on implications of alleged tracking for individual privacy and federal communications policy.Also on Monday, Minnesota Senator Al Franken, chairman of the U. S. Senate Judiciary Subcommittee on Privacy, Technology and the Law, announced he had scheduled a mobile privacy hearing on May 10 and asked representatives from Apple and Google to speak at the hearing.Meanwhile, Lisa Madigan, Attorney General of U.S. state of Illinois, on Monday called for a meeting with Apple and Google executives on the location-tracking reports, citing her ongoing effort to protect consumers' personal information online.Last Friday, two iPhone users filed a class action suit against Apple in Tempa, Florida, accusing the company of invasion of privacy and computer fraud and seeking a judge's order to bar the alleged data collection.Last Thursday, U.S. congressman Edward Markey asked Apple CEO Steve Jobs to make a response within 15 business days or no later than May 12, saying "Apple needs to safeguard personal location information of its users to ensure that an iPhone doesn't become an iTrack."On Saturday, Markey called for a congressional investigation into the privacy practices of Apple and Google. In a statement, he made clear that he thinks the data collection is potentially dangerous, saying predators could have hacked into an iPhone or Android phone to find out children's location information.Apple is also reportedly being investigated in South Korea, France, Germany and Italy over the alleged tracking practice.